摘要
钠-葡萄糖转运蛋白2抑制剂作为一种新型的口服降糖药物,不仅能降低血糖,还能影响人体血尿酸的代谢。本文综述了近年来各种钠-葡萄糖转运蛋白2抑制剂对2型糖尿病患者血尿酸影响的相关研究,并总结了钠-葡萄糖转运蛋白2抑制剂降尿酸的可能机制。
As a new oral hypoglycemic drug,sodium-glucose cotransporter 2 inhibitors can not only lower blood glucose,but also improve the metabolism of uric acid.This article reviews the effects of various sodium-glucose cotransporter 2 inhibitors on serum uric acid in patients with type 2 diabetes in recent years.In addition,the possible mechanisms of this action of sodium-glucose cotransporter 2 inhibitors are summarized.
作者
花慧
祝超瑜
魏丽
HUA Hui;ZHU Chao-yu;WEI Li(College of Fisheries and Life Sciences,Shanghai Ocean University,Shanghai 201306,China;Shanghai Jiaotong University Affiliated Sixth People's Hospital,Shanghai 200233,China)
出处
《解放军药学学报》
2023年第6期551-556,共6页
Pharmaceutical Journal of Chinese People's Liberation Army
